Company: STAA
Filing Date: 2025-09-16
Form Type: DEFA14A
Source: 0001193125-25-204402
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFA14A
Chunk 1
---
 substantial competitive and macro challenges in the markets STAAR serves. Our business is heavily exposed to China, which faces significant economic uncertainty and where sales trends have been declining despite actions taken by the Company. Notably, STAAR’s common stock closed at only $18.49 per share just prior to the announcement of the Alcon agreement. Vote “FOR” the Merger Proposal TODAY Your vote is importantbecause the merger is subject to approval by the holders of a majority of STAAR’s outstanding shares of common stock. Failure to vote will have the same effect as an “AGAINST” vote. To help ensure you receive the compelling, premium $28.00 per share cash value afforded by the Alcon merger please vote “ FOR” the merger proposal TODAY. If you have questions about voting your shares, please contact our proxy solicitor, Innisfree M&A Incorporated: Stockholders, please call toll-free: (877) 750-8233. Banks and brokerage firms, please call: (212) 750-5833. On behalf of the STAAR Board, thank you for your continued support of STAAR. Sincerely,

| Stephen C Farrell       |     | Elizabeth Yeu, M.D. |
| Chief Executive Officer |     | Board Chair         |

Additional Information About the Merger and Where to Find It This communication relates to the proposed transaction involving STAAR. In connection with the proposed transaction, STAAR has filed relevant materials with the U.S. Securities and Exchange Commission (the “SEC”), including STAAR’s definitive proxy statement on Schedule 14A (the “Proxy Statement”), on September 16, 2025. The Proxy Statement was first sent to STAAR stockholders on September 16, 2025. This communication is not a substitute for the Proxy Statement or any other document that STAAR may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF STAAR ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC’s website, www.sec.gov, or by visiting STAAR